SE9902675D0 - Pharmaceutical formulations, doses & regimens - Google Patents
Pharmaceutical formulations, doses & regimensInfo
- Publication number
- SE9902675D0 SE9902675D0 SE9902675A SE9902675A SE9902675D0 SE 9902675 D0 SE9902675 D0 SE 9902675D0 SE 9902675 A SE9902675 A SE 9902675A SE 9902675 A SE9902675 A SE 9902675A SE 9902675 D0 SE9902675 D0 SE 9902675D0
- Authority
- SE
- Sweden
- Prior art keywords
- doses
- regimens
- pharmaceutical formulations
- glucocorticosteroid
- antifungal azole
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 abstract 8
- 230000000843 anti-fungal effect Effects 0.000 abstract 4
- 229940121375 antifungal agent Drugs 0.000 abstract 4
- 239000003862 glucocorticoid Substances 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 206010067125 Liver injury Diseases 0.000 abstract 1
- 231100000234 hepatic damage Toxicity 0.000 abstract 1
- 230000008818 liver damage Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902675A SE9902675D0 (sv) | 1999-07-12 | 1999-07-12 | Pharmaceutical formulations, doses & regimens |
| AU61942/00A AU6194200A (en) | 1999-07-12 | 2000-07-07 | Pharmaceutical formulations comprising a glucocorticosteroid and an antifungal azole, for increasing the local mucosal tissue concentration of glucocorticosteroids in the gi tract |
| PCT/SE2000/001468 WO2001003702A1 (en) | 1999-07-12 | 2000-07-07 | Pharmaceutical formulations comprising a glucocorticosteroid and an antifungal azole, for increasing the local mucosal tissue concentration of glucocorticosteroids in the gi tract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9902675A SE9902675D0 (sv) | 1999-07-12 | 1999-07-12 | Pharmaceutical formulations, doses & regimens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE9902675D0 true SE9902675D0 (sv) | 1999-07-12 |
Family
ID=20416479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9902675A SE9902675D0 (sv) | 1999-07-12 | 1999-07-12 | Pharmaceutical formulations, doses & regimens |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU6194200A (sv) |
| SE (1) | SE9902675D0 (sv) |
| WO (1) | WO2001003702A1 (sv) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2153681C (en) * | 1993-01-21 | 2004-05-25 | Marc Karel Jozef Francois | Topical ketoconazole compositions |
| US5658881A (en) * | 1994-10-14 | 1997-08-19 | Twk, Inc. | Method for topical inhibition of the metabolic activity of cytochrome P450 |
-
1999
- 1999-07-12 SE SE9902675A patent/SE9902675D0/sv unknown
-
2000
- 2000-07-07 WO PCT/SE2000/001468 patent/WO2001003702A1/en active Application Filing
- 2000-07-07 AU AU61942/00A patent/AU6194200A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU6194200A (en) | 2001-01-30 |
| WO2001003702A1 (en) | 2001-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101580A2 (hu) | Gélesedő gyógyászati készítmények | |
| ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
| ATE554750T1 (de) | Hydrophobe pharmazeutische wirkstoffe enthaltende zubereitungen | |
| BR0215184A (pt) | composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada | |
| EP1226104A4 (en) | PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS USED TO DIFFUSER ACTIVE AGENTS | |
| TR199800902T2 (xx) | Ecza form�lasyonlar�. | |
| BR0011772A (pt) | Conjugado de droga-oligÈmero, composição farmacêutica, método de solubilização de uma droga em uma microemulsão, e, métodos para fornecer um conjugado de droga ativa - hidrófilo e um conjugado de droga ativa - peg a um sìtio de um indivìduo | |
| ES2109899T1 (es) | Metodo, composiciones y kits para aumentar la biodisponibilidad oral de agentes farmaceuticos. | |
| CY1112562T1 (el) | Φαρμακευτικες συνθεσεις για τη στοματικη χορηγηση της καλσιτονινης | |
| ATE224717T1 (de) | Oral anzuwendende arzneizubereitungen enthaltend eine benzhydrylpiperazine und eine zyklodextrin | |
| KR950031069A (ko) | 골손실의 억제 및 혈청 콜레스테롤의 강하 방법 | |
| ATE235895T1 (de) | Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis | |
| BR0014652A (pt) | Fabricação de conjugados de agente terapêutico-poliglutamato | |
| NO20030897D0 (no) | Fremgangsmåte for fremstilling av farmasöytiske sammensetninger for anvendelse med blöte gelatin formuleringer | |
| DE60313359D1 (de) | Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate | |
| DE60019334D1 (de) | Antivirale arznei | |
| WO1999051271A3 (en) | Compositions comprising glycol derivatives and alcohols | |
| TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
| AR022589A1 (es) | UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER | |
| DE50012571D1 (de) | Biotin enthaltende galenische formulierung | |
| DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
| AU4955200A (en) | A method of improving bioavailability of orally administered drugs, a method of screening for enhancers of such bioavailability and novel pharmaceutical compositions for oral delivery of drugs | |
| CY1105168T1 (el) | Διφασικη συνθεση με τραμαδολη | |
| AR025060A1 (es) | Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa | |
| CO4970832A1 (es) | Nuevas formulaciones y procesos para su fabricacion |